MedCap AB (Sweden) Analysis
| MCAP Stock | SEK 551.00 3.00 0.55% |
MedCap AB is overvalued with Real Value of 452.55 and Hype Value of 551.0. The main objective of MedCap AB stock analysis is to determine its intrinsic value, which is an estimate of what MedCap AB is worth, separate from its market price. There are two main types of MedCap AB's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect MedCap AB's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of MedCap AB's stock to identify patterns and trends that may indicate its future price movements.
The MedCap AB stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. MedCap AB is usually not traded on NationalDay, International Workers ' Day, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday. MedCap Stock trading window is adjusted to Europe/Stockholm timezone.
MedCap |
MedCap Stock Analysis Notes
About 30.0% of the company outstanding shares are owned by corporate insiders. The book value of MedCap AB was now reported as 57.83. The company has Price/Earnings (P/E) ratio of 197.02. MedCap AB recorded earning per share (EPS) of 7.98. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 27th of September 2016. MedCap AB is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. MedCap AB was founded in 2001 and is based in Stockholm, Sweden. MedCap AB operates under Medical Equipment classification in Sweden and is traded on Stockholm Stock Exchange. To find out more about MedCap AB contact the company at 46 8 34 71 10 or learn more at https://www.medcap.se.MedCap AB Investment Alerts
| MedCap AB has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| About 30.0% of the company outstanding shares are owned by corporate insiders |
MedCap Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.57 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MedCap AB's market, we take the total number of its shares issued and multiply it by MedCap AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.MedCap Profitablity
MedCap AB's profitability indicators refer to fundamental financial ratios that showcase MedCap AB's ability to generate income relative to its revenue or operating costs. If, let's say, MedCap AB is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, MedCap AB's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of MedCap AB's profitability requires more research than a typical breakdown of MedCap AB's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.15 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.15. Technical Drivers
As of the 30th of November, MedCap AB secures the Downside Deviation of 2.39, risk adjusted performance of 0.0486, and Mean Deviation of 1.98. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MedCap AB, as well as the relationship between them.MedCap AB Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. MedCap AB middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for MedCap AB. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
MedCap AB Outstanding Bonds
MedCap AB issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. MedCap AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most MedCap bonds can be classified according to their maturity, which is the date when MedCap AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
MedCap AB Predictive Daily Indicators
MedCap AB intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of MedCap AB stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
MedCap AB Forecast Models
MedCap AB's time-series forecasting models are one of many MedCap AB's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MedCap AB's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About MedCap Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how MedCap AB prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MedCap shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as MedCap AB. By using and applying MedCap Stock analysis, traders can create a robust methodology for identifying MedCap entry and exit points for their positions.
MedCap AB is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. MedCap AB was founded in 2001 and is based in Stockholm, Sweden. MedCap AB operates under Medical Equipment classification in Sweden and is traded on Stockholm Stock Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding MedCap AB to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Additional Tools for MedCap Stock Analysis
When running MedCap AB's price analysis, check to measure MedCap AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedCap AB is operating at the current time. Most of MedCap AB's value examination focuses on studying past and present price action to predict the probability of MedCap AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedCap AB's price. Additionally, you may evaluate how the addition of MedCap AB to your portfolios can decrease your overall portfolio volatility.